138 related articles for article (PubMed ID: 21198939)
1. Relationship between prostate-specific antigen and obesity in prostate cancer screening: analysis of a large cohort in Japan.
Kubota Y; Seike K; Maeda S; Shinohara Y; Iwata M; Sugimoto N
Int J Urol; 2011 Jan; 18(1):72-5. PubMed ID: 21198939
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
3. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.
Zhang J; Ma M; Nan X; Sheng B
Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409334
[TBL] [Abstract][Full Text] [Related]
4. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
5. Obesity and screening PSA levels among men undergoing an annual physical exam.
Rundle A; Neugut AI
Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
[TBL] [Abstract][Full Text] [Related]
6. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
7. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
[TBL] [Abstract][Full Text] [Related]
8. Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
Klaassen Z; Howard LE; Moreira DM; Andriole GL; Terris MK; Freedland SJ
Prostate; 2017 Apr; 77(5):466-470. PubMed ID: 27990661
[TBL] [Abstract][Full Text] [Related]
9. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.
Wallner LP; Morgenstern H; McGree ME; Jacobson DJ; St Sauver JL; Jacobsen SJ; Sarma AV
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):501-8. PubMed ID: 21242331
[TBL] [Abstract][Full Text] [Related]
10. Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a hospital-based cross-sectional survey, 2004-2006.
Ando R; Nagaya T; Hashimoto Y; Suzuki S; Itoh Y; Umemoto Y; Ikeda N; Tozawa K; Kohri K; Tokudome S
Urology; 2008 Sep; 72(3):561-5. PubMed ID: 18514773
[TBL] [Abstract][Full Text] [Related]
11. Relationship between prostate-specific antigen and body mass index according to age: lower prostate-specific antigen in middle-aged overweight and obese Korean men.
Yang WJ; Cheon SH; Kim YS; Kim DJ; Seong do H; Song YS; Cho SY; Cho IR; Kim SI; Kim SJ; Kim CI; Choi YD; Hong SJ; Im H; Cho JS
Urol Int; 2010; 85(2):143-6. PubMed ID: 20558981
[TBL] [Abstract][Full Text] [Related]
12. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
13. Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.
Liang Y; Ankerst DP; Sanchez M; Leach RJ; Thompson IM
Urology; 2010 Nov; 76(5):1268.e1-6. PubMed ID: 20739049
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution.
Kryvenko ON; Diaz M; Matoso A; Kates M; Cohen J; Swanson GP; Epstein JI
Urology; 2016 Apr; 90():141-7. PubMed ID: 26773349
[TBL] [Abstract][Full Text] [Related]
15. [Impact of obesity on PSA in prostate cancer screening].
Larré S; Azzouzi AR; Cancel-Tassin G; Cormier L; Villette JM; Hoffmann P; Drelon I; Baschet F; Mangin P; Cussenot O
Prog Urol; 2007 Jun; 17(4):815-8. PubMed ID: 17633992
[TBL] [Abstract][Full Text] [Related]
16. Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced.
Li F; Shen Z; Lu Y; Yun J; Fan Y
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1731-4. PubMed ID: 22850805
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen density: a better index of obesity-related PSA decrease in ostensibly healthy Korean men with a PSA <3.0 ng/mL.
Kim JH; Doo SW; Yang WJ; Song YS; Kwon SS
Urology; 2013 Apr; 81(4):849-52. PubMed ID: 23465165
[TBL] [Abstract][Full Text] [Related]
18. [Association between obesity-related plasma hemodilution and the concentration of prostate specific antigen].
Li F; Yin X; Li D; Yin Z; Qi S; Shi H; Gao J; Zhang X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1721-4. PubMed ID: 26714904
[TBL] [Abstract][Full Text] [Related]
19. Obesity and prostate cancer screening among African-American and Caucasian men.
Fowke JH; Signorello LB; Underwood W; Ukoli FA; Blot WJ
Prostate; 2006 Sep; 66(13):1371-80. PubMed ID: 16752375
[TBL] [Abstract][Full Text] [Related]
20. The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.
Bañez LL; Albisinni S; Freedland SJ; Tubaro A; De Nunzio C
World J Urol; 2014 Apr; 32(2):323-8. PubMed ID: 22847453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
